News

RVNC LAWSUIT ALERT: Levi & Korsinsky Notifies Revance Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=125002&wire=1 or contact Joseph E. Levi, Esq.

01/24/2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Revance Therapeutics Inc

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Revance Therapeutics Inc ("RVNC" or the "Company") (NASDAQ:RVNC) Stock purchased prior to August 11, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of Revance by Crown Laboratories, Inc. ("Crown").

01/24/2025

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Revance Therapeutics, Inc. (RVNC) a buy, sell, or hold?

Revance Therapeutics, Inc. (RVNC) can sell. Click on Rating Page for detail.

What is Revance Therapeutics, Inc.'s stock price?

The price of Revance Therapeutics, Inc. (RVNC) is 3.65 and it was updated on 2025-01-25 01:11:35.

Is Revance Therapeutics, Inc. (RVNC) overvalued or undervalued?

Currently Revance Therapeutics, Inc. (RVNC) is in undervalued.

News

From:

To:

News
Class Action Filed Against Revance Therapeutics, Inc. (RVNC) Seeking Recovery for Investors - Contact Levi & Korsinsky NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=124974&wire=1 or contact Joseph E. Levi, Esq. Fri, Jan. 24, 2025
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - RVNC NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ:RVNC) and certain officers. The class action, filed in the United States District Court for the Middle District of Tennessee, and docketed under 25-cv- 00018 is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Revance securities between February 29, 2024 and December 6, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. Fri, Jan. 24, 2025
Revance Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 4, 2025 to Discuss Your Rights - RVNC NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=124929&wire=1 or contact Joseph E. Levi, Esq. Fri, Jan. 24, 2025
RVNC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Revance Therapeutics, Inc. to Contact the Firm Today! NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance" or "the Company") (NASDAQ:RVNC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Revance securities between February 29, 2024 and December 6, 2024, both dates inclusive (the "Class Period"). Fri, Jan. 24, 2025
Shareholders that lost money on Revance Therapeutics, Inc.(RVNC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More NEW YORK , Jan. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Revance investors who were adversely affected by alleged securities fraud between February 29, 2024 and December 6, 2024. Fri, Jan. 24, 2025

Transcripts

Transcipts Data
Revance Therapeutics, Inc. (RVNC) on Q2 2024 Results - Earnings Call Transcript SA Transcripts Fri, Aug. 09, 2024
Revance Therapeutics, Inc. (RVNC) on Q1 2024 Results - Earnings Call Transcript SA Transcripts Thu, May. 09, 2024
Revance Therapeutics, Inc. (RVNC) on Q4 2023 Results - Earnings Call Transcript SA Transcripts Thu, Feb. 29, 2024
Revance Therapeutics, Inc. (RVNC) on Q3 2023 Results - Earnings Call Transcript SA Transcripts Wed, Nov. 08, 2023
Revance Therapeutics, Inc. (RVNC) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Tue, Aug. 08, 2023
Revance Therapeutics, Inc. (RVNC) on Q1 2023 Results - Earnings Call Transcript SA Transcripts Tue, May. 09, 2023
Revance Therapeutics, Inc. (RVNC) on Q4 2022 Results - Earnings Call Transcript SA Transcripts Tue, Feb. 28, 2023
Revance Therapeutics, Inc. (RVNC) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Tue, Nov. 08, 2022
Revance Therapeutics, Inc. (RVNC) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Tue, Aug. 09, 2022
Revance Therapeutics, Inc. (RVNC) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Tue, May. 10, 2022
Revance Therapeutics, Inc. (RVNC) on Q4 2021 Results - Earnings Call Transcript SA Transcripts Mon, Feb. 28, 2022
Revance Therapeutics, Inc. (RVNC) on Q3 2021 Results - Earnings Call Transcript SA Transcripts Wed, Nov. 10, 2021
Revance Therapeutics, Inc. (RVNC) on Q2 2021 Results - Earnings Call Transcript SA Transcripts Sun, Aug. 08, 2021
Revance Therapeutics, Inc. (RVNC) on Q1 2021 Results - Earnings Call Transcript SA Transcripts Mon, May. 10, 2021

SEC Filings

SEC Filings
Revance Therapeutics, Inc. (RVNC) - SC TO-T/A SEC Filings 01/21/2025
Revance Therapeutics, Inc. (RVNC) - SC 14D9/A SEC Filings 01/21/2025
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/21/2025
Revance Therapeutics, Inc. (RVNC) - SC 14D9/A SEC Filings 01/17/2025
Revance Therapeutics, Inc. (RVNC) - SC TO-T/A SEC Filings 01/13/2025
Revance Therapeutics, Inc. (RVNC) - SC 14D9/A SEC Filings 01/13/2025
Revance Therapeutics, Inc. (RVNC) - SCHEDULE 13G SEC Filings 01/10/2025
Revance Therapeutics, Inc. (RVNC) - SC 14D9/A SEC Filings 01/08/2025
Revance Therapeutics, Inc. (RVNC) - SCHEDULE 13D/A SEC Filings 01/06/2025
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/03/2025
Revance Therapeutics, Inc. (RVNC) - SC TO-T/A SEC Filings 01/02/2025
Revance Therapeutics, Inc. (RVNC) - SC 14D9/A SEC Filings 01/02/2025
Revance Therapeutics, Inc. (RVNC) - SCHEDULE 13D/A SEC Filings 12/19/2024
Revance Therapeutics, Inc. (RVNC) - SC TO-T SEC Filings 12/12/2024
Revance Therapeutics, Inc. (RVNC) - SC 14D9 SEC Filings 12/12/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/12/2024
Revance Therapeutics, Inc. (RVNC) - SC14D9C SEC Filings 12/09/2024
Revance Therapeutics, Inc. (RVNC) - SC TO-C SEC Filings 12/09/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/09/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/05/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/03/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/29/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/26/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/19/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/19/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/07/2024
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/07/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/01/2024
Revance Therapeutics, Inc. (RVNC) - SCHEDULE 13G/A SEC Filings 10/31/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/28/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 10/23/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/18/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 10/07/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/04/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 09/23/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 09/16/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 09/09/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 09/09/2024
Revance Therapeutics, Inc. (RVNC) - SC14D9C SEC Filings 09/05/2024
Revance Therapeutics, Inc. (RVNC) - SC TO-C SEC Filings 09/05/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/28/2024
Revance Therapeutics, Inc. (RVNC) - SC14D9C SEC Filings 08/12/2024
Revance Therapeutics, Inc. (RVNC) - SC TO-C SEC Filings 08/12/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/12/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/09/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/08/2024
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/08/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/02/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/09/2024
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/09/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/03/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/03/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 04/17/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 04/09/2024
Revance Therapeutics, Inc. (RVNC) - DEFA14A SEC Filings 03/21/2024
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/21/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/19/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/08/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/05/2024
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 03/05/2024
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 03/04/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/04/2024
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 02/29/2024
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 02/29/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/28/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/14/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/13/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/13/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/09/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/06/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/06/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/02/2024
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/25/2024
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/08/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/03/2024
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/18/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/15/2023
Revance Therapeutics, Inc. (RVNC) - S-3ASR SEC Filings 11/14/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/08/2023
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/08/2023
Revance Therapeutics, Inc. (RVNC) - SC 13D/A SEC Filings 10/24/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 09/19/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/07/2023
Revance Therapeutics, Inc. (RVNC) - SC 13D SEC Filings 09/01/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/31/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 08/15/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/14/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/08/2023
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/08/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 08/04/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/05/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/20/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/13/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/05/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/16/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/09/2023
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/09/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/08/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/05/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/02/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 04/19/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 04/04/2023
Revance Therapeutics, Inc. (RVNC) - DEFA14A SEC Filings 03/31/2023
Revance Therapeutics, Inc. (RVNC) - DEFA14A SEC Filings 03/23/2023
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/23/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/17/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/09/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/03/2023
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 03/03/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/02/2023
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 02/28/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/28/2023
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 02/28/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/16/2023
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/14/2023
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/14/2023
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/13/2023
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/09/2023
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/03/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/03/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/02/2023
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/27/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/23/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/18/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/10/2023
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/09/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/03/2023
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/16/2022
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 12/09/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/08/2022
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/08/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/20/2022
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/14/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 09/14/2022
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 09/14/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 09/13/2022
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 09/13/2022
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 09/12/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 09/08/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/09/2022
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/09/2022
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/05/2022
Revance Therapeutics, Inc. (RVNC) - 4/A SEC Filings 05/13/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/10/2022
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 05/10/2022
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/10/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/06/2022
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/06/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 04/21/2022
Revance Therapeutics, Inc. (RVNC) - DEFA14A SEC Filings 03/24/2022
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/24/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/24/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/21/2022
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/17/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/08/2022
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 02/28/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/28/2022
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 02/28/2022
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/17/2022
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/14/2022
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/11/2022
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/10/2022
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/08/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/07/2022
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/04/2022
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/04/2022
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/03/2022
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/18/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/18/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/07/2022
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/04/2022
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/22/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/17/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/15/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/06/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/29/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/10/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/09/2021
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/09/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/15/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/15/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/28/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 08/17/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/05/2021
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/05/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/30/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/28/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 07/06/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/02/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/26/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/10/2021
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/10/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/07/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/07/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 04/16/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 04/12/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 04/06/2021
Revance Therapeutics, Inc. (RVNC) - DEFA14A SEC Filings 03/24/2021
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/24/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/17/2021
Revance Therapeutics, Inc. (RVNC) - PRE 14A SEC Filings 03/12/2021
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/11/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/10/2021
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 03/10/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/08/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/05/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/02/2021
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 03/02/2021
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 02/25/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/22/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/19/2021
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/16/2021
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/12/2021
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/10/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/08/2021
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/05/2021
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/04/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/04/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/03/2021
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/02/2021
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/29/2021
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 01/29/2021
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 01/28/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/27/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/26/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/07/2021
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/04/2021
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/22/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/22/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/02/2020
Revance Therapeutics, Inc. (RVNC) - S-3ASR SEC Filings 11/27/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/27/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/20/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/09/2020
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/09/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/30/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/15/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/14/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/02/2020
Revance Therapeutics, Inc. (RVNC) - 4/A SEC Filings 09/30/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/30/2020
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 08/10/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/06/2020
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/06/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/27/2020
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 07/27/2020
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 07/24/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 07/24/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/02/2020
Revance Therapeutics, Inc. (RVNC) - EFFECT SEC Filings 06/25/2020
Revance Therapeutics, Inc. (RVNC) - EFFECT SEC Filings 06/24/2020
Revance Therapeutics, Inc. (RVNC) - 424B3 SEC Filings 06/24/2020
Revance Therapeutics, Inc. (RVNC) - S-4/A SEC Filings 06/23/2020
Revance Therapeutics, Inc. (RVNC) - CORRESP SEC Filings 06/23/2020
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 06/17/2020
Revance Therapeutics, Inc. (RVNC) - S-4 SEC Filings 06/10/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 06/01/2020
Revance Therapeutics, Inc. (RVNC) - 8-K/A - Current report SEC Filings 05/21/2020
Revance Therapeutics, Inc. (RVNC) - 425 SEC Filings 05/21/2020
Revance Therapeutics, Inc. (RVNC) - 425 SEC Filings 05/20/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/19/2020
Revance Therapeutics, Inc. (RVNC) - 425 SEC Filings 05/19/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/15/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/15/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/07/2020
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/07/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 04/17/2020
Revance Therapeutics, Inc. (RVNC) - DEFA14A SEC Filings 03/26/2020
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/26/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/17/2020
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 03/13/2020
Revance Therapeutics, Inc. (RVNC) - SEC STAFF LETTER SEC Filings 02/27/2020
Revance Therapeutics, Inc. (RVNC) - SEC STAFF SEC Filings 02/27/2020
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 02/26/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/24/2020
Revance Therapeutics, Inc. (RVNC) - 4/A SEC Filings 02/19/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/19/2020
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 02/19/2020
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/14/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/14/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/10/2020
Revance Therapeutics, Inc. (RVNC) - SEC STAFF LETTER SEC Filings 02/07/2020
Revance Therapeutics, Inc. (RVNC) - SEC STAFF SEC Filings 02/07/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/07/2020
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/06/2020
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/05/2020
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 02/03/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/24/2020
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 01/21/2020
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/17/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/17/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/10/2020
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/09/2020
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/08/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/03/2020
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/17/2019
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 12/10/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/04/2019
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 12/04/2019
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 12/03/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 11/12/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/04/2019
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/04/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/15/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/15/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/27/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 08/12/2019
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/06/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/05/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/18/2019
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 07/18/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 07/17/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/02/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/17/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 06/06/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/06/2019
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 06/06/2019
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 05/17/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/10/2019
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/09/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/08/2019
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/25/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/19/2019
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 03/18/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/18/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/15/2019
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 02/28/2019
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 02/28/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/26/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/20/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/14/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/13/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/12/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/06/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/29/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/28/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/25/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/25/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/23/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/17/2019
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 01/17/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/17/2019
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/15/2019
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 01/15/2019
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/04/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/04/2019
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/02/2019
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 12/17/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/14/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/04/2018
Revance Therapeutics, Inc. (RVNC) - CORRESP SEC Filings 11/21/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/21/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/16/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/09/2018
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 11/08/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/07/2018
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 11/07/2018
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/02/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/01/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/17/2018
Revance Therapeutics, Inc. (RVNC) - CORRESP SEC Filings 10/15/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/11/2018
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 09/13/2018
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 09/06/2018
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/03/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/02/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/06/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/03/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 06/22/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/22/2018
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 06/22/2018
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 06/11/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/29/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/24/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/11/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/11/2018
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/09/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/08/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/03/2018
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 05/03/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 04/19/2018
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 04/10/2018
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 04/09/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/23/2018
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/20/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/16/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/15/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/13/2018
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 03/13/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/09/2018
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 03/02/2018
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 03/02/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/28/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/16/2018
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/09/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/09/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/09/2018
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/08/2018
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/07/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/30/2018
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/25/2018
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/23/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/17/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/08/2018
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/04/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/03/2018
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/28/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/18/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/07/2017
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 12/07/2017
Revance Therapeutics, Inc. (RVNC) - S-3ASR SEC Filings 12/05/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/05/2017
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 12/05/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/24/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/09/2017
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/03/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/02/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/20/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/16/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/22/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/20/2017
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 09/20/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/07/2017
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 09/07/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 09/06/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 08/25/2017
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/04/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/03/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/02/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/05/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/14/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 06/06/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 06/05/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/31/2017
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 05/24/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/24/2017
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 05/23/2017
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 05/22/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/18/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/12/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/12/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/09/2017
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/09/2017
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/24/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/17/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/15/2017
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 02/28/2017
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 02/28/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/27/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/24/2017
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/13/2017
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/09/2017
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/09/2017
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/08/2017
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/03/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/01/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/30/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/27/2017
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/25/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/12/2017
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/11/2017
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/05/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/03/2017
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/30/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/16/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/12/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/25/2016
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/04/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/03/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/28/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 08/16/2016
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/05/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/04/2016
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 07/22/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/06/2016
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 07/06/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 07/05/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/05/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/15/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 06/13/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 06/03/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/23/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/11/2016
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/10/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/09/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/09/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 04/13/2016
Revance Therapeutics, Inc. (RVNC) - EFFECT SEC Filings 03/28/2016
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 03/25/2016
Revance Therapeutics, Inc. (RVNC) - CORRESP SEC Filings 03/23/2016
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 03/18/2016
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/18/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/09/2016
Revance Therapeutics, Inc. (RVNC) - S-3 SEC Filings 03/07/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/07/2016
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 03/04/2016
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 03/04/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/02/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/29/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/17/2016
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/12/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/12/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/11/2016
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/10/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/10/2016
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/09/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/04/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/01/2016
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 01/28/2016
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 01/26/2016
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 01/21/2016
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 01/12/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/08/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/07/2016
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/04/2016
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/23/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/16/2015
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 12/16/2015
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 12/14/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/14/2015
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 12/07/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/17/2015
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/10/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/09/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/04/2015
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 11/04/2015
Revance Therapeutics, Inc. (RVNC) - EFFECT SEC Filings 11/03/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/02/2015
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 11/02/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 10/29/2015
Revance Therapeutics, Inc. (RVNC) - CORRESP SEC Filings 10/28/2015
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 10/27/2015
Revance Therapeutics, Inc. (RVNC) - S-3 SEC Filings 10/16/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/04/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 08/19/2015
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/07/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/06/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/21/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 07/02/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 07/02/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/19/2015
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 06/09/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 06/05/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 06/03/2015
Revance Therapeutics, Inc. (RVNC) - 4/A SEC Filings 05/27/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/27/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/21/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/19/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/15/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/14/2015
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/14/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/13/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/04/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 04/21/2015
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 04/03/2015
Revance Therapeutics, Inc. (RVNC) - ARS SEC Filings 03/30/2015
Revance Therapeutics, Inc. (RVNC) - DEF 14A SEC Filings 03/26/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/23/2015
Revance Therapeutics, Inc. (RVNC) - EFFECT SEC Filings 03/19/2015
Revance Therapeutics, Inc. (RVNC) - 424B5 SEC Filings 03/19/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/19/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/11/2015
Revance Therapeutics, Inc. (RVNC) - S-3 SEC Filings 03/04/2015
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 03/04/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/02/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/02/2015
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 03/02/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/27/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/18/2015
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/17/2015
Revance Therapeutics, Inc. (RVNC) - SC 13G/A SEC Filings 02/13/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/03/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/30/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/22/2015
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 01/13/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 01/12/2015
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 01/09/2015
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 12/22/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/19/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/15/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/11/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 12/01/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 11/20/2014
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 11/13/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/12/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 11/04/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/30/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 10/21/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/19/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 09/02/2014
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 09/02/2014
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 08/29/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/29/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 08/20/2014
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 08/13/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 08/12/2014
Revance Therapeutics, Inc. (RVNC) - EFFECT SEC Filings 06/19/2014
Revance Therapeutics, Inc. (RVNC) - 424B4 SEC Filings 06/19/2014
Revance Therapeutics, Inc. (RVNC) - S-1/A SEC Filings 06/18/2014
Revance Therapeutics, Inc. (RVNC) - FWP SEC Filings 06/18/2014
Revance Therapeutics, Inc. (RVNC) - S-1/A SEC Filings 06/16/2014
Revance Therapeutics, Inc. (RVNC) - S-1 SEC Filings 06/06/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/21/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 05/14/2014
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 05/14/2014
Revance Therapeutics, Inc. (RVNC) - 10-Q - Quarterly Report SEC Filings 05/14/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 05/13/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 04/10/2014
Revance Therapeutics, Inc. (RVNC) - 10-K - Current report SEC Filings 03/28/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/26/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/21/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 03/06/2014
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 03/06/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/05/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 03/04/2014
Revance Therapeutics, Inc. (RVNC) - SC 13G SEC Filings 02/24/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/24/2014
Revance Therapeutics, Inc. (RVNC) - S-8 SEC Filings 02/14/2014
Revance Therapeutics, Inc. (RVNC) - 8-K - Current report SEC Filings 02/11/2014
Revance Therapeutics, Inc. (RVNC) - 4 SEC Filings 02/11/2014
Revance Therapeutics, Inc. (RVNC) - EFFECT SEC Filings 02/06/2014
Revance Therapeutics, Inc. (RVNC) - CT ORDER SEC Filings 02/06/2014
Revance Therapeutics, Inc. (RVNC) - 424B4 SEC Filings 02/06/2014
Revance Therapeutics, Inc. (RVNC) - S-1MEF SEC Filings 02/05/2014
Revance Therapeutics, Inc. (RVNC) - 3 SEC Filings 02/05/2014
Revance Therapeutics, Inc. (RVNC) - CORRESP SEC Filings 02/04/2014
Revance Therapeutics, Inc. (RVNC) - CERTNAS SEC Filings 02/04/2014
Revance Therapeutics, Inc. (RVNC) - 8-A12B SEC Filings 02/04/2014
Revance Therapeutics, Inc. (RVNC) - S-1/A SEC Filings 02/03/2014
Revance Therapeutics, Inc. (RVNC) - S-1/A SEC Filings 01/27/2014
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 01/15/2014
Revance Therapeutics, Inc. (RVNC) - CORRESP SEC Filings 01/15/2014
Revance Therapeutics, Inc. (RVNC) - S-1 SEC Filings 12/31/2013
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 11/26/2013
Revance Therapeutics, Inc. (RVNC) - DRS/A SEC Filings 11/06/2013
Revance Therapeutics, Inc. (RVNC) - D SEC Filings 10/23/2013
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 06/19/2013
Revance Therapeutics, Inc. (RVNC) - DRS/A SEC Filings 06/04/2013
Revance Therapeutics, Inc. (RVNC) - UPLOAD SEC Filings 05/16/2013
Revance Therapeutics, Inc. (RVNC) - DRS SEC Filings 04/19/2013
Revance Therapeutics, Inc. (RVNC) - D SEC Filings 02/22/2013
Revance Therapeutics, Inc. (RVNC) - D/A SEC Filings 01/09/2013
Revance Therapeutics, Inc. (RVNC) - D/A SEC Filings 09/14/2012
Revance Therapeutics, Inc. (RVNC) - D SEC Filings 10/06/2011
Revance Therapeutics, Inc. (RVNC) - D/A SEC Filings 06/14/2011
Revance Therapeutics, Inc. (RVNC) - D SEC Filings 02/03/2011
Revance Therapeutics, Inc. (RVNC) - D/A SEC Filings 11/18/2010
Revance Therapeutics, Inc. (RVNC) - D/A SEC Filings 08/23/2010
Revance Therapeutics, Inc. (RVNC) - D/A SEC Filings 06/01/2010
Revance Therapeutics, Inc. (RVNC) - D SEC Filings 12/23/2009

Press Releases

StockPrice Release
Rvnc lawsuit alert: levi & korsinsky notifies revance therapeutics, inc. investors of a class action lawsuit and upcoming deadline 01/24/2025
Shareholder alert: levi & korsinsky, llp notifies shareholders of an investigation into revance therapeutics inc 01/24/2025
Class action filed against revance therapeutics, inc. (rvnc) seeking recovery for investors - contact levi & korsinsky 01/24/2025
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in revance therapeutics, inc. of class action lawsuit and upcoming deadlines - rvnc 01/24/2025
Revance therapeutics, inc. sued for securities law violations - contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/24/2025
Rvnc investor alert: bronstein, gewirtz and grossman, llc reminds shareholders of revance therapeutics, inc. to contact the firm today! 01/24/2025
Shareholders that lost money on revance therapeutics, inc.(rvnc) urged to join class action - contact levi & korsinsky to learn more 01/24/2025
Shareholder alert: levi & korsinsky, llp initiates investigation into revance therapeutics inc. 01/23/2025
Class action filed against revance therapeutics, inc. (rvnc) seeking recovery for investors - contact levi & korsinsky 01/23/2025
Revance therapeutics, inc. (rvnc) investors who lost money have opportunity to lead securities fraud lawsuit 01/23/2025
Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/23/2025
Levi & korsinsky reminds shareholders of a lead plaintiff deadline of march 4, 2025 in revance therapeutics, inc. lawsuit - rvnc 01/23/2025
Revance therapeutics, inc. is being sued for securities law violations and affected investors are urged to contact the schall law firm 01/23/2025
Rvnc investor alert: bronstein, gewirtz and grossman, llc reminds investors of revance therapeutics, inc. to contact the firm today! 01/23/2025
Shareholders of revance therapeutics, inc. should contact the gross law firm before march 4, 2025 to discuss your rights - rvnc 01/23/2025
Revance therapeutics, inc. sued for securities law violations - investors should contact levi & korsinsky for more information - rvnc 01/22/2025
Bragar eagel & squire, p.c. reminds investors that class action lawsuits have been filed against bioage and revance and encourages investors to contact the firm 01/22/2025
Shareholders that lost money on revance therapeutics, inc.(rvnc) should contact levi & korsinsky about pending class action - rvnc 01/22/2025
Shareholder rights law firm robbins llp reminds rvnc shareholders with large losses to seek counsel for the revance therapeutics, inc. class action 01/22/2025
Shareholder alert: levi & korsinsky, llp notifies investors of an investigation into revance therapeutics inc. 01/22/2025
Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights – rvnc 01/22/2025
Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/22/2025
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in revance therapeutics, inc. of class action lawsuit and upcoming deadlines - rvnc 01/22/2025
Rvnc lawsuit alert: levi & korsinsky notifies revance therapeutics, inc. investors of a class action lawsuit and upcoming deadline 01/22/2025
The schall law firm invites shareholders with losses to join a securities fraud case against revance therapeutics, inc. 01/22/2025
Levi & korsinsky announces the filing of a securities class action on behalf of revance therapeutics, inc. (rvnc) shareholders 01/22/2025
Rvnc stockholders have opportunity to lead revance therapeutics, inc. class action lawsuit – contact bronstein, gewirtz and grossman, llc today! 01/22/2025
Shareholders that lost money on revance therapeutics, inc. (rvnc) should contact levi & korsinsky about pending class action - rvnc 01/21/2025
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in revance therapeutics, inc. of class action lawsuit and upcoming deadlines - rvnc 01/21/2025
Class action filed against revance therapeutics, inc. (rvnc) - march 4, 2025 deadline to join - contact levi & korsinsky 01/21/2025
Shareholder alert: levi & korsinsky, llp notifies shareholders of an investigation into revance therapeutics inc 01/21/2025
The gross law firm notifies revance therapeutics, inc. investors of a class action lawsuit and upcoming deadline – rvnc 01/21/2025
Revance therapeutics, inc. is being sued for securities law violations and affected investors are urged to contact the schall law firm 01/21/2025
Investors who lost money on revance therapeutics, inc. (rvnc) should contact levi & korsinsky about pending class action - rvnc 01/21/2025
Rvnc shareholders have opportunity to lead revance therapeutics, inc. class action lawsuit – contact bronstein, gewirtz and grossman, llc today! 01/21/2025
Crown laboratories and revance amend the a&r merger agreement to increase offer price to $3.65 per share and extend existing tender offer 01/21/2025
Shareholders of revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/21/2025
Levi & korsinsky reminds revance investors of the pending class action lawsuit with a lead plaintiff deadline of march 4, 2025 - rvnc 01/20/2025
Rvnc investor alert: bronstein, gewirtz & grossman llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit 01/20/2025
Shareholder alert: levi & korsinsky, llp informs shareholders of an investigation into revance therapeutics inc 01/20/2025
Levi & korsinsky announces the filing of a securities class action on behalf of revance therapeutics, inc. (rvnc) shareholders 01/20/2025
Rvnc investors have opportunity to lead revance therapeutics, inc. securities fraud lawsuit with the schall law firm 01/20/2025
The schall law firm invites shareholders with losses to join a securities fraud case against revance therapeutics, inc. 01/20/2025
Rvnc investors have opportunity to lead revance therapeutics, inc. class action lawsuit – contact bronstein, gewirtz and grossman, llc today! 01/20/2025
Investors in revance therapeutics, inc. should contact the gross law firm before march 4, 2025 to discuss your rights - rvnc 01/20/2025
Rvnc investor alert: bronstein, gewirtz & grossman llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit 01/19/2025
Class action filed against revance therapeutics, inc. (rvnc) - march 4, 2025 deadline to join - contact levi & korsinsky 01/19/2025
Revance therapeutics, inc. is being sued for securities law violations and impacted investors are urged to contact the schall law firm 01/19/2025
Class action filed against revance therapeutics, inc. (rvnc) - march 4, 2025 deadline to join - contact levi & korsinsky 01/19/2025
Rvnc investor alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. stockholders have opportunity to lead class action lawsuit! 01/19/2025
Contact levi & korsinsky by march 4, 2025 deadline to join class action against revance therapeutics, inc.(rvnc) 01/18/2025
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in revance therapeutics, inc. of class action lawsuit and upcoming deadlines - rvnc 01/18/2025
The schall law firm invites shareholders with losses to join a securities fraud case against revance therapeutics, inc. 01/18/2025
Levi & korsinsky reminds shareholders of a lead plaintiff deadline of march 4, 2025 in revance therapeutics, inc. lawsuit - rvnc 01/17/2025
Rvnc investor alert: bronstein, gewirtz & grossman llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit 01/17/2025
Shareholder alert: levi & korsinsky, llp notifies investors of an investigation into revance therapeutics inc 01/17/2025
Revance therapeutics, inc. class action: levi & korsinsky reminds revance investors of the pending class action lawsuit with a lead plaintiff deadline of march 4, 2025 - rvnc 01/17/2025
Revance therapeutics, inc. (rvnc) investors who lost money have opportunity to lead securities fraud lawsuit 01/17/2025
Revance therapeutics, inc. is being sued for securities law violations and affected investors are urged to contact the schall law firm 01/17/2025
Contact levi & korsinsky by march 4, 2025 deadline to join class action against revance therapeutics, inc. (rvnc) 01/17/2025
Rvnc investor alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. shareholders have opportunity to lead class action lawsuit! 01/17/2025
Levi & korsinsky notifies revance therapeutics, inc. investors of a class action lawsuit and upcoming deadline - rvnc 01/17/2025
March 4, 2025 deadline: contact levi & korsinsky to join class action suit against rvnc 01/16/2025
Shareholder alert: levi & korsinsky, llp notifies investors of an investigation into revance therapeutics inc 01/16/2025
Rvnc shareholder alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. investors have opportunity to lead class action lawsuit! 01/16/2025
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in revance therapeutics, inc. of class action lawsuit and upcoming deadlines - rvnc 01/16/2025
The schall law firm invites shareholders with losses to join a securities fraud case against revance therapeutics, inc. 01/16/2025
Revance therapeutics, inc. sued for securities law violations - contact the gross law firm before march 4, 2025 to discuss your rights - rvnc 01/16/2025
Class action filed against revance therapeutics, inc. (rvnc) - march 4, 2025 deadline to join - contact levi & korsinsky 01/15/2025
Rvnc shareholders with large losses are encouraged to seek counsel to lead the revance therapeutics, inc. class action - contact robbins llp today 01/15/2025
Levi & korsinsky announces the filing of a securities class action on behalf of revance therapeutics, inc.(rvnc) shareholders 01/15/2025
Shareholder alert: levi & korsinsky, llp informs shareholders of an investigation into revance therapeutics inc 01/15/2025
Shareholders of revance therapeutics, inc. should contact the gross law firm before march 4, 2025 to discuss your rights - rvnc 01/15/2025
Class action filed against revance therapeutics, inc. (rvnc) seeking recovery for investors - contact levi & korsinsky 01/15/2025
Revance therapeutics, inc. (rvnc) investors who lost money have opportunity to lead securities fraud lawsuit 01/15/2025
Revance therapeutics, inc. sued for securities law violations - investors should contact levi & korsinsky for more information - rvnc 01/15/2025
Revance therapeutics inc. is being sued for securities law violations and impacted investors are urged to contact the schall law firm 01/15/2025
Levi & korsinsky reminds shareholders of a lead plaintiff deadline of march 4, 2025 in revance therapeutics, inc. lawsuit - rvnc 01/15/2025
Rvnc investor alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. investors have opportunity to lead class action lawsuit! 01/15/2025
Levi & korsinsky notifies shareholders of revance therapeutics, inc. (rvnc) of a class action lawsuit and an upcoming deadline 01/14/2025
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in revance therapeutics, inc. of class action lawsuit and upcoming deadlines - rvnc 01/14/2025
Shareholders that lost money on revance therapeutics, inc.(rvnc) urged to join class action - contact levi & korsinsky to learn more 01/14/2025
Rvnc investor alert: bronstein, gewirtz & grossman llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit 01/14/2025
Shareholder alert: levi & korsinsky, llp informs shareholders of an investigation into revance therapeutics inc 01/14/2025
March 4, 2025 deadline: contact levi & korsinsky to join class action suit against rvnc 01/14/2025
The schall law firm invites shareholders with losses to join a securities fraud case against revance therapeutics, inc. 01/14/2025
Levi & korsinsky notifies revance therapeutics, inc. investors of a class action lawsuit and upcoming deadline - rvnc 01/14/2025
Rvnc shareholder alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. stockholders with losses have opportunity to lead class action lawsuit! 01/14/2025
Shareholder alert: levi & korsinsky, llp notifies investors of an investigation into revance therapeutics inc 01/13/2025
Revance therapeutics, inc. sued for securities law violations - contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/13/2025
Levi & korsinsky notifies shareholders of revance therapeutics, inc.(rvnc) of a class action lawsuit and an upcoming deadline 01/13/2025
Levi & korsinsky reminds shareholders of a lead plaintiff deadline of march 4, 2025 in revance lawsuit - rvnc 01/13/2025
Revance therapeutics inc is being sued for securities law violations and impacted investors are urged to contact the schall law firm 01/13/2025
Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/13/2025
Rvnc shareholder alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. shareholders with losses have opportunity to lead class action lawsuit! 01/13/2025
Crown laboratories extension of tender offer to acquire revance therapeutics, inc. 01/13/2025
Shareholders that lost money on revance therapeutics, inc.(rvnc) urged to join class action - contact the gross law firm to learn more 01/13/2025
Class action filed against revance therapeutics, inc. (rvnc) seeking recovery for investors - contact levi & korsinsky 01/12/2025
Levi & korsinsky notifies revance therapeutics, inc. investors of a class action lawsuit and upcoming deadline - rvnc 01/12/2025
Rvnc stockholder alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit! 01/12/2025
The schall law firm invites shareholders with losses to join a securities fraud case against revance therapeutics, inc. 01/12/2025
Levi & korsinsky notifies shareholders of revance therapeutics, inc.(rvnc) of a class action lawsuit and an upcoming deadline 01/11/2025
Revance therapeutics inc. is being sued for securities law violations and impacted investors are urged to contact the schall law firm 01/11/2025
Rvnc investor alert: bronstein, gewirtz & grossman llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit 01/10/2025
Shareholder alert: levi & korsinsky, llp initiates investigation into revance therapeutics inc. 01/10/2025
Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/10/2025
Rvnc lawsuit alert: levi & korsinsky notifies revance therapeutics, inc. investors of a class action lawsuit and upcoming deadline 01/10/2025
Rvnc shareholder alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit! 01/10/2025
Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/10/2025
The schall law firm invites shareholders with losses to join a securities fraud case against revance therapeutics, inc. 01/10/2025
March 4, 2025 deadline: contact levi & korsinsky to join class action suit against rvnc 01/10/2025
Kirby mcinerney llp reminds revance therapeutics, inc. (rvnc) investors of class action filing and encourages investors to contact the firm 01/10/2025
Revance therapeutics, inc. securities fraud class action lawsuit pending: contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/10/2025
Revance therapeutics, inc. sued for securities law violations - investors should contact levi & korsinsky for more information - rvnc 01/10/2025
Rvnc investors have opportunity to lead revance therapeutics, inc. securities fraud lawsuit with the schall law firm 01/10/2025
Class action filed against revance therapeutics, inc. (rvnc) seeking recovery for investors – contact levi & korsinsky 01/09/2025
Rvnc investor alert: bronstein, gewirtz & grossman llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit 01/09/2025
Shareholders of revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/09/2025
Revance therapeutics, inc. investor alert: shareholder rights law firm robbins llp reminds shareholders of the class action against rvnc 01/09/2025
Levi & korsinsky notifies shareholders of revance therapeutics, inc.(rvnc) of a class action lawsuit and an upcoming dedlinea 01/09/2025
Revance therapeutics inc. is being sued for securities law violations and impacted investors are encouraged to contact the schall law firm 01/09/2025
Levi & korsinsky notifies shareholders of revance therapeutics, inc.(rvnc) of a class action lawsuit and an upcoming deadline 01/09/2025
Rvnc investor alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit! 01/09/2025
The gross law firm reminds shareholders of a lead plaintiff deadline of march 4, 2025 in revance lawsuit - rvnc 01/09/2025
Rvnc lawsuit alert: levi & korsinsky notifies revance therapeutics, inc. investors of a class action lawsuit and upcoming deadline 01/08/2025
Class action filed against revance therapeutics, inc. (rvnc) - march 4, 2025 deadline to join – contact levi & korsinsky 01/08/2025
Levi & korsinsky reminds revance therapeutics, inc. investors of the pending class action lawsuit with a lead plaintiff deadline of march 4, 2025 - rvnc 01/08/2025
The schall law firm urges shareholders with losses to join a securities fraud case against revance therapeutics, inc. 01/08/2025
Revance therapeutics, inc. securities fraud class action lawsuit pending: contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/08/2025
Rvnc investor alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. investors with losses have opportunity to lead class action lawsuit! 01/08/2025
Class action filed against revance therapeutics, inc. (rvnc) seeking recovery for investors - contact levi & korsinsky 01/07/2025
Revance alert: bragar eagel & squire, p.c. announces that a class action lawsuit has been filed against revance therapeutics, inc. and encourages investors to contact the firm 01/07/2025
Rvnc investors have opportunity to lead revance therapeutics, inc. securities fraud lawsuit with the schall law firm 01/07/2025
Revance therapeutics, inc. securities fraud class action lawsuit pending: contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/07/2025
Stockholder notice: robbins llp informs stockholders of the revance therapeutics, inc. class action lawsuit 01/07/2025
Revance therapeutics, inc. class action: levi & korsinsky reminds revance investors of the pending class action lawsuit with a lead plaintiff deadline of march 4, 2025 - rvnc 01/07/2025
Rvnc investor alert: bronstein, gewirtz & grossman llc announces that revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit 01/07/2025
Law offices of frank r. cruz encourages revance therapeutics, inc. (rvnc) investors to inquire about securities fraud class action 01/07/2025
March 4, 2025 deadline: contact levi & korsinsky to join class action suit against - rvnc 01/07/2025
Gainey mckenna & egleston announces a class action lawsuit has been filed against revance therapeutics, inc. (rvnc) 01/07/2025
Levi & korsinsky reminds revance investors of the pending class action lawsuit with a lead plaintiff deadline of march 4, 2025 - rvnc 01/07/2025
Rvnc shareholder alert: bronstein, gewirtz and grossman, llc announces that revance therapeutics, inc. stockholders with substantial losses have opportunity to lead class action lawsuit! 01/07/2025
Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/06/2025
Glancy prongay & murray llp, a leading securities fraud law firm encourages revance therapeutics, inc. (rvnc) investors to inquire about securities fraud class action 01/06/2025
Law offices of howard g. smith encourages revance therapeutics, inc. (rvnc) investors to inquire about securities fraud class action 01/06/2025
Investors in revance therapeutics, inc. should contact levi & korsinsky before march 4, 2025 to discuss your rights - rvnc 01/06/2025
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in revance therapeutics, inc. of class action lawsuit and upcoming deadlines - rvnc 01/06/2025
Class action filed against revance therapeutics, inc. (rvnc) seeking recovery for investors - contact levi & korsinsky 01/06/2025